TITLE

Immunologic impact of the intestine in metabolic disease

AUTHOR(S)
Winer, Daniel A.; Winer, Shawn; Dranse, Helen J.; Lam, Tony K. T.
PUB. DATE
January 2017
SOURCE
Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p33
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Obesity and diabetes are associated with increased chronic low-grade inflammation and elevated plasma glucose levels. Although inflammation in the fat and liver are established features of obesity-associated insulin resistance, the intestine is emerging as a new site for immunologic changes that affect whole-body metabolism. Specifically, microbial and dietary factors incurred by diet-induced obesity influence underlying innate and adaptive responses of the intestinal immune system. These responses affect the maintenance of the intestinal barrier, systemic inflammation, and glucose metabolism. In this Review we propose that an understanding of the changes to the intestinal immune system, and how these changes influence systemic immunity and glucose metabolism in a whole-body integrative and a neuronal-dependent network, will unveil novel intestinal pathologic and therapeutic targets for diabetes and obesity.
ACCESSION #
120696695

 

Related Articles

  • Inflammatory mechanisms linking obesity and metabolic disease. Saltiel, Alan R.; Olefsky, Jerrold M. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p1 

    There are currently over 1.9 billion people who are obese or overweight, leading to a rise in related health complications, including insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration. The finding that obesity and metabolic disorder are...

  • Hypothalamic inflammation in obesity and metabolic disease. Jais, Alexander; Brüning, Jens C. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p24 

    Over the last years, hypothalamic inflammation has been linked to the development and progression of obesity and its sequelae. There is accumulating evidence that this inflammation not only impairs energy balance but also contributes to obesity-associated insulin resistance. Elevated activation...

  • Filling the Void. Vash, Peter // JAMA: Journal of the American Medical Association;4/4/2012, Vol. 307 Issue 13, p1381 

    A personal narrative is presented which explores the author's experience of treating Paula's obesity who weighed more than 325 pounds.

  • Intestinal handling of glucose in rats treated with Kolaviron (A biflavonoid of Garcinia Kola seed). Olaleye, S. B.; Odukanmi, O. A. // Proceedings of the Physiological Society;2013, p936P 

    Kolaviron (KV) a fraction of Garcinia kola has been found to have hypoglycemic effect on glucose metabolism. The mechanism of its hypoglycemic effect was investigated. KV was isolated according to Iwu et al(1990).The study was executed in three phases. Phase I was conducted to investigate the...

  • The influence of a long-term growth hormone treatment on lipid and glucose metabolism: a randomized trial in short Japanese children born small for gestational age. Reiko Horikawa; Toshiaki Tanaka; Hiromi Nishinaga; Yoshihisa Ogawa; Susumu Yokoya // International Journal of Pediatric Endocrinology;10/26/2016, Vol. 2016, p1 

    Background: Long-term growth hormone (GH) treatments in short children born small for gestational age (SGA) restore lipid metabolism, but also increase insulin resistance. The aim of this study was to evaluate the influence of long-term GH therapy on lipid and glucose metabolism as well as its...

  • POHYBOVÁ INTERVENCE JAKOU SOUČÁST LÉČENÍ NADVÁHY A OBEZITY. Poděbradská, R. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;Aug2011, Vol. 18 Issue 2, p50 

    This article contains new aspects of obesity as a disease and an insight into physical activity in treating obesity. Currently, obesity is the most frequent metabolic disease (9) and it is important to search for a common, effective application for its prevention and treatment. Ideally, for a...

  • Obesity in Preschoolers: Behavioral Correlates and Directions for Treatment. Kuhl, Elizabeth S.; Clifford, Lisa M.; Stark, Lori J. // Obesity (19307381);Jan2012, Vol. 20 Issue 1, p3 

    Nearly 14% of American preschoolers (ages 2-5) are obese (BMI = 95th percentile for age and gender), yet this group has received little attention in the obesity intervention literature. This review examines what is known about behavioral correlates of obesity in preschoolers and the...

  • Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai // Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107 

    Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue...

  • Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance. Li, Huqun; Fang, Maosheng; Xu, Mingzhen; Li, Shihong; Du, Juan; Li, Weiyong; Chen, Hui // PLoS ONE;12/14/2016, Vol. 11 Issue 12, p1 

    Background: Atypical antipsychotics such as olanzapine cause metabolic side effects leading to obesity and insulin resistance. The underlying mechanisms remain elusive. In this study we investigated the effects of chronic treatment of olanzapine on the fatty acid composition of plasma in mice....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics